Facebook Twitter LinkedIn Instagram Email Printer Google Plus

John Rudoy, PhD

Director, Marsh & McLennan Advantage, Healthcare

With the pandemic accelerating transformation, AMC strategies must reimagine their operations to deliver new value.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

A Guide to Economic Recovery for Health System CFOs

How prioritizing long-term organizational changes immediately will ensure stability post-crisis.

Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare
Global Head, Provider, Health and Life Sciences, Oliver Wyman

It’s senior leadership’s job — including board members — to mitigate the effects of this pandemic.

Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

Specialty drugs represent an opportunity to better serve patients, but also pose risks.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Actuarial, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

Men hold most (87 percent) of C-suite roles at healthcare’s top ranks. But why?

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

Insights in your inbox

Subscribe

They Just Have to Persuade People to Like Them

Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Oliver Wyman's 2018 Consumer Survey explores healthcare's supply and demand disconnect.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Former Partner, Health & Life Sciences, Oliver Wyman

Women, healthcare's primary consumers, are 20 percent more likely than men are to express frustrations with the healthcare system.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman

Some of our 2018 predictions on consolidation, pharma, and investment came true, while others were less predictable.

Director, Marsh & McLennan Advantage, Healthcare

As merger activity heightens, some leverage retail with pharma to meet consumer demand.

Partner, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare
Engagement Manager, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe